Home > Insider Trading > Filing (0001144204-15-071313)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1137883	Brainstorm Cell Therapeutics Inc.	BCLI	Biological Products, (No Disgnostic Substances) (2836)	207273918

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1517390	Mordechai Friedman	C/O Brainstorm Cell Therapeutics Inc. 3 University Plaza Drive, Suite 320 Hackensack NJ 07601		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-14	5,000	$0.75	5,000	No	4	M	Direct
Common Stock	Disposition	2015-12-14	5,000	$2.57	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-12-14	5,000	$0.00	5,000	$0.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,666		2024-08-15	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.56 to $2.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The option, representing a right to purchase a total of 16,666 shares of common stock of the Issuer, became vested and exercisable in 12 consecutive, equal monthly installments commencing on September 15, 2014 and fully vested and exercisable on August 15, 2015.